Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses

Antiviral Chemistry and Chemotherapy

Volumn 19, Issue 1, 2008, Pages 41-47

  Sepúlveda, Claudia S ^a   Fascio, Mirta L ^b   Mazzucco, María B ^a   Docampo Palacios, Maite L ^c   Pellón, Rolando F ^c   García, Cybele C ^a   D'Accorso, Norma B ^b   Damonte, Elsa B ^a  

^a Laboratorio de Virologia Ciudad Autonoma de Buenos Aires   (Argentina)

^b DEPARTAMENTO DE QUÍMICA ORGÁNICA   (Argentina)

^c Centro de Quimica Farmaceutica   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

10 ALLYL 2 FLUOR 9(10H) ACRIDONE; 10 ALLYL 6 CHLORO 2 FLUOR 9(10H) ACRIDONE; 10 ALLYL 7 CHLORO 9(10H) ACRIDONE; 6 CHLORO 10 (3 METHYL 2 BUTENYL) 9(10H) ACRIDONE; ACRIDONE DERIVATIVE; ANTIVIRUS AGENT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DENGUE VIRUS; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; JUNIN VIRUS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SUBSTITUTION REACTION; VIROGENESIS; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS STRAIN; ANIMAL; CELL SURVIVAL; CERCOPITHECUS; DENGUE; DRUG EFFECT; SYNTHESIS; VERO CELL; VIRUS CULTURE; VIRUS INFECTION;

ACRIDONES; ANIMALS; ANTIVIRAL AGENTS; ARENAVIRIDAE INFECTIONS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; JUNIN VIRUS; PLAQUE ASSAY; VERO CELLS;

EID: 47049098913     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020801900106     Document Type: Article

References (30)

1. Andrei G, De Clercq E. Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral Res 1993; 22:45-75.
2. Damonte EB, Coto CE. Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv Virus Res 2002; 58:125-155.
3. Damonte EB, Pujol CA, Coto CE. Prospects for the therapy and prevention of dengue virus infections. Adv Virus Res 2004; 63:239-285.
4. Leyssen P, De Clercq E, Neyts J. Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev 2002; 13:67-82.
5. Sidwell RW, Smee DF. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 2003; 57:101-111.
6. Enría DA, Maiztegui JI. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res 1994; 23:23-31.
7. Fisher-Hoch SP, Ghorie S, Parker L, Huggins J. Unexpected adverse reactions during a clinical trial in rural West Africa. Antiviral Res 1992; 19:139-147.
8. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 1995; 346:472-475.
9. Akanitapichat P, Lowden CT, Bastow KF. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication. Antiviral Res 2000; 45: 123-134.
10. Goodell JR, Madhok AA, Hiasa H, Ferguson DM. Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity. Bioorg Med Chem 2006; 14:5467-5480.
11. Lowden CT, Bastow KF. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives. Antiviral Res 2003; 59:143-154.
12. Itoigawa M, Ito C, Wu T-S, et al. Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Lett 2003; 193:133-138.
13. Zarubaev VV, Slita AV, Krivitskaya VZ, Sirotkin AK, Kovalenko AL, Chatterjee NK. Direct antiviral effect of cycloferon (10-carboxymethyl-9- acridanone) against adenovirus type 6 in vitro. Antiviral Res 2003; 58:131-137.
14. Akanitapichat P, Bastow KF. The antiviral agent 5-chloro-1,3- dihydroxyacridone interferes with assembly and maturation of herpes simplex virus. Antiviral Res 2002; 53:113-126.
15. Vance JR, Bastow KF. Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone. Biochem Pharmacol 1999; 58:703-708.
16. Fujiwara M, Okamoto M, Okamoto M, et al. Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells. Antiviral Res 1999 43:179-189.
17. Turpin JA, Buckheit Jr RW, Derse D, et al. Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription. Antimicrob Agents Chemother 1998; 42:487-494.
18. Tabarrini O, Manfroni G, Fravolini A, et al. Synthesis and anti-BVDV activity of acridones as new potential antiviral agents. J Med Chem 2006; 49:2621-2627.
19. Watterson SH, Chen P, Zhao Y, et al. Acridone-based inhibitors of inosine 5′-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2- yl)-2-fluoro-9-oxo-9,10-dihydroxyacridine-3-carboxamide (BMS-566419). J Med Chem 2007; 50:3730-3742.
20. Nair V, Shu Q. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antivir Chem Chemother 2007; 18:245-258.
21. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-103.
22. Pellón RF, Carrasco R, Rodés L. Synthesis of N-Phenylantranilic acids using water as solvent. Synth Commun 1993; 23:1447-1453.
23. Docampo ML, Pellón RF. Synthesis of N-phenylanthranilic acid derivatives using water as solvent in the presence of ultrasound irradiation. Synth Commun 2003; 33:1771-1775.
24. Mahamoud A, Galy JP, Vincent EJ. Synthesis of (allenic) N-propadienyl- and (acetylenic) N-(1-propynyl)-acridanones using phase-tranfer catalysis. Synthesis 1981; 11:917-918.
25. Fascio ML, D'Accorso NB, Pellón RF, Docampo ML. Synthesis of novel carbohydrate acridinone derivatives with potential biological activities by using 1,3-dipolar cycloaddition. Synth Commun 2007; 37:4209-4217.
26. García CC, Candurra NA, Damonte EB. Mode of inactivation of arenaviruses by disulfide-based compounds. Antiviral Res 2002; 55:437-446.
27. Talarico LB, Damonte EB. Interference in dengue virus adsorption and uncoating by carrageenans. Virology 2007; 363:473-185.
28. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against flaviviruses. Antiviral Res 2003; 58:73-79.
29. Takhampunya R, Ubol S, Houng H-S, Cameron CE, Padmanabhan R. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J Gen Virol 2006; 87:1947-1952.
30. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8: 225-230.